Get the latest news, insights, and market updates on LQDA (Liquidia Corporation). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Three Elite Growth Companies With Strong Insider Ownership
As major U.S. stock indices like the Dow Jones, S&P 500, and Nasdaq are poised for solid weekly and monthly gains following strong earnings reports from tech giants Amazon and Apple, investors are keenly observing market dynamics. In such a climate, growth companies with high insider ownership can offer unique insights into potential long-term value creation as they often align management's interests with those of shareholders. Oct 31, 2025 - $LQDA
Niagen Bioscience (NAGE) Reports Next Week: What to Expect
Niagen Bioscience (NAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Oct 28, 2025 - $LQDA
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
MORRISVILLE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025. The company will host a webcast at 8:30 a.m. Eastern Time to discuss its financial results and provide a corporate update. The webcast will be available on Liquidia's website at https://liquidia.c Oct 27, 2025 - $LQDA
Wall Street Analysts Believe LIQUIDIA CORP (LQDA) Could Rally 50.94%: Here's is How to Trade
The consensus price target hints at a 50.9% upside potential for LIQUIDIA CORP (LQDA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Oct 21, 2025 - $LQDA
Liquidia Corporation to Host R&D Day in New York City on October 28, 2025
MORRISVILLE, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it will host a Research & Development Day (R&D Day) on Tuesday, October 28, 2025, in New York City which will be webcast from 2:00 p.m. to 4:30 p.m. Eastern Standard Time. The event will feature presentations from Liquidia’s management team alongside three key opinion leaders (KOL Oct 7, 2025 - $LQDA
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple